Jan. 24–27, 2022 | Virtual
The safety of our attendees at our in-person events are of the utmost importance at the Society for Immunotherapy of Cancer (SITC). Given the recent increase in the COVID-19 virus and the Omicron variant, the SITC has made the decision to convert the upcoming Cancer Immunotherapy Winter School and Society for Immunotherapy of Cancer (SITC) Clinical Immuno-Oncology Network (SCION) Workshop to fully virtual programs to ensure the safety of our attendees. Cancer Immunotherapy Winter School will still be held Jan. 24 – 28, 2022. The SCION Workshop will be held Jan. 24 – 27, 2022. SCION participants will receive an email details about the schedule and their participation virtually.The Society for Immunotherapy of Cancer (SITC) Clinical Immuno-Oncology Network (SCION) Workshop is an intimate immunotherapy clinical trial development program, led by experts in the field who are equipped to help their assigned students navigate through the unique considerations that accompany immunotherapy treatments.Designed to address the unique considerations for designing clinical trial protocols focused on cancer immunotherapy, the SCION Workshop connects participants with experienced faculty in the field and dedicated patient advocates to advise on clinical trial protocol development.
Please note, upon acceptance into the program, SCION Workshop applicants will be required to be in person and register for SITC's fourth annual Cancer Immunotherapy Winter School.Cancer Immunotherapy Winter School is being held as a fully virtual program. Visit the Cancer Immunotherapy Winter School webpage for more information.
Registrants will receive an email before the program with instructions on how to join the virtual SCION Workshop sessions.
SITC’s Clinical Immuno-Oncology Network (SCION) Workshop is supported, in part, through sponsorships from Alkermes, Inc., AstraZeneca Pharmaceuticals LP; Novartis Oncology, and Sanofi Genzyme (as of 01/12/2022).
If you have questions about this program, please contact the SITC Education team.
Applications submissions were due Sept. 10 by 5 p.m. PDT and the application site has now closed.
Tel: +1 414 271 2456 | Fax: +1 414 276 3349 | Email: email@example.com